Form 4: Chidozie Ugwumba Sells Clene Inc. Stake, Exits Reporting

Reporting person Chidozie Ugwumba has sold a significant portion of his stake in Clene Inc., falling below the 10% ownership threshold.

Summary

• Chidozie Ugwumba, through SymBiosis II, LLC, sold a total of 95,473 shares of Clene Inc. (CLNN) common stock.
• The sales occurred on May 11, 2026 (22,177 shares at $6.75) and May 12, 2026 (73,296 shares at $6.20).
• Following these transactions, the reporting person's beneficial ownership dropped below the 10% threshold.
• The reporting person is no longer subject to Section 16 reporting requirements for Clene Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event; while insider selling can be perceived negatively, this appears to be a routine divestment by a major shareholder to fall below the 10% reporting threshold.

Positives

• The sale provides liquidity to the reporting entity, SymBiosis II, LLC.

Negatives

• The sale of a significant block of shares by a 10% owner may be perceived as a lack of long-term confidence in the stock price by a major stakeholder.

Risks

• The exit of a major 10% shareholder can lead to increased volatility in the company's share price due to the change in ownership structure.

Future Outlook

No specific future outlook or guidance was provided in this filing, as it is a standard disclosure of changes in beneficial ownership.

Management Comments

• As a result of the transaction reported within this Form 4, the Reporting Person's beneficial ownership has fallen below 10% of the outstanding shares of Common Stock of the Issuer.

Industry Context

StockSavvy.ai notes that the exit of a 10% owner is a common occurrence in the biotech and small-cap sector as institutional investors rebalance portfolios or reach the end of their investment horizon.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for reporting changes in beneficial ownership for entities holding more than 10% of a company's equity.

Related Party Transactions

• The shares were held by SymBiosis II, LLC, an entity associated with the reporting person.

Stakeholder Impact

• Shareholders may experience short-term price volatility due to the liquidation of a significant block of shares.

Next Steps

• The reporting person is no longer required to file Form 4 reports for Clene Inc. unless they re-acquire a 10% stake or become an officer/director.

Key Dates

Keywords

Clene Inc, CLNN, Insider Trading, Form 4, Beneficial Ownership, Stock Sale